Mairuike Bio
麦锐克
Mairuike Bio
Biotech/Healthcare
Mairuike Biotech, founded in 2022, was established and is led by a US-trained PhD returnee. The company has assembled a team of high-level R&D personnel in biomedical research from China and abroad, and has built its proprietary innovation platform on core microRNA technology.
Latest round: Angel (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.